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Abstract 
Objective: Oxygen is one of the most important environmental factors for tumor 
development. In this study, we examined pO2 in malignant ascites in patients with 
peritoneal carcinomatosis.  
Methods: In 21 patients with peritoneal dissemination of gastric cancer, ascitic fluid was 
collected and its pH, pCO2 and pO2 were determined using a blood gas analyzer.  
Results: In 21 patients, pH of malignant ascites was significantly lower than that of 
arterial blood (7.39 ± 0.07, 7.44 ± 0.02, p < 0.05). Accordingly, pCO2 tended to be higher 
in ascites than in arterial blood. Unexpectedly, pO2 in malignant ascites showed relatively 
high values (90.4 ± 27.72 mm Hg), which were mostly the same as those of arterial blood 
(97.09 ± 10.33 mm Hg, p = 0.858). Even in 19 patients whose samples were collected at 
bedside in room air, pO2 of malignant ascites was 85.94 ± 23.94 mm Hg, which was 
patently higher than that in venous blood or in solid tumor tissues.  
Conclusion: Since the oxygen level critically affects the sensitivity of tumor cells to 
chemotherapeutic agents through metabolic transformation, the oxygenic condition in 
the peritoneal cavity may be beneficial for the progression of peritoneal metastasis, and 
also clinically important in considering the efficacy of chemotherapy. 
 
Introduction 
Peritoneal metastasis with malignant ascites is the most life-threatening mode of 
metastasis and recurrence in patients with gastric [1] as well as ovarian cancer [2]. 
Peritoneal metastasis is considered to develop from carcinoma cells detached from the 
serosal surface of the primary site and dispersed in the peritoneal cavity. In general, the  
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survival of seeded cells is largely dependent on the environment, in other words, the soil 
[3]. Oxygen supply is one of the most important environmental factors for cancer cell 
survival [4]. However, the oxygenic condition in the abdominal cavity is largely unknown. 
In this study, therefore, we collected ascitic fluid from patients with peritoneal 
dissemination of gastric cancer, and measured pO2 as well as pCO2 and pH. 
Patients and Methods 
Twenty-one patients with peritoneal dissemination of gastric cancer who were admitted to the 
University of Tokyo Hospital, Japan, between March and June 2010, were included in this study. All 
patients had a considerable amount of ascites and had received systemic and/or intraperitoneal 
chemotherapy. In 19 patients, samples of ascites were collected through a drainage catheter inserted into 
the abdominal cavity, or through an access port system with the end of the catheter placed in the pelvic 
cavity and an access port system implanted in the subcutaneous space [5]. In 16 of the 19 patients, 
arterial blood was obtained by arterial puncture on the same day. In the other 2 cases, an insufficient 
amount of ascites was collected, and it was thus obtained just after laparotomy under general anesthesia. 
The samples were kept in a syringe with an airtight seal, and immediately analyzed with a blood gas 
analyzer, ABL800 (Radiometer, Copenhagen, Denmark). The results were statistically examined by 
paired Student’s t test or simple regression analysis, and differences with p < 0.05 were considered to be 
significant. 
Results 
As shown in table 1, the pH of malignant ascites was 7.39 ± 0.07, which was slightly 
but significantly lower than the pH of arterial blood (7.44 ± 0.02, p = 0.033). Consistent 
with this, ascites showed a slightly higher pCO2 (43.70 ± 5.5 mm Hg) than that of arterial 
blood (40.72 ± 3.46 mm Hg), although the difference was not statistically significant (p = 
0.124). Interestingly, pO2 in malignant ascites showed considerably high levels (90.4 ± 
27.72 mm Hg), which were mostly the same as those of arterial blood (97.09 ± 10.33 mm 
Hg, p = 0.858). 
In patients 5 and 8, in whom ascites was collected after laparotomy, pO2 was 151 and 
133 mm Hg, respectively. Because they were controlled under general anesthesia, they 
were considered to be subjected to a higher percentage of O2 gas than that in room air. 
However, even in the other 19 patients, pO2 of ascites was 85.94 ± 23.94 mm Hg, which 
was not significantly different from that of arterial blood, 97.19 ± 10.40 mm Hg (p = 
0.149). 
When pO2 in ascites and arterial blood was compared in 16 patients in whom ascites 
was obtained at bedside in room air, a positive trend was observed, although the 
correlation was not statistically significant (fig. 1). 
Discussion 
Our data have demonstrated that malignant ascites in gastric cancer patients showed 
an unexpectedly high oxygen tension, which was almost the same as that of arterial blood. 
pO2 was sensitive to the change of circumstances, and thus the procedure of sample 
acquisition and method of measurement are very important in assessment of the data. In 
our study, however, ascites was directly obtained through an intraperitoneal catheter or a  
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subcutaneously placed port, kept in a syringe with an airtight seal, and immediately 
analyzed with a blood gas analyzer, just as for analysis of arterial blood. Therefore, it is 
unlikely that the relatively high pO2 values in malignant ascites are attributable to 
potential artifact during measurement. 
A literature search showed little information on PaO2 in ascites. In 1977, Sheckman et 
al. [6] reported that the mean pO2 of ascitic fluid from 10 patients with liver cirrhosis was 
43 mm Hg. Based on their data, they concluded that this pO2 was so high that anaerobic 
bacteria cannot survive in it and they are rarely the cause of spontaneous bacterial 
peritonitis. In 1982, Giltin et al. [7] also examined the ascitic fluid of patients with 
spontaneous bacterial peritonitis in alcoholic cirrhosis and showed that pO2 of their 
ascites was 50–82 mm Hg. Although the main aim of their study was to investigate the pH 
of ascitic fluid and they did not mention pO2 much, their data showed apparently lower 
values than ours. On the other hand, Simmen et al. [8] reported that pO2 of ascitic fluid 
with or without infection was 29 (0–160) and 144 (49–174) mm Hg, respectively. This 
suggests that ascitic fluid may have a higher pO2 in some conditions, although the method 
and timing of sample collection varied greatly in their study. 
More recently, however, Noh et al. [9] have reported that pO2 of ascitic fluid of patients 
with non-serosal invasive gastric cancer obtained during surgery was 136.49 ± 0.66 mm 
Hg. This value was considerably higher than that of cirrhotic ascites reported previously 
and is consistent with our results, or rather higher than our pO2 data. In their study, they 
collected ascitic fluid during abdominal surgery under general anesthesia. Since the 
anesthetic gas of operated patients is usually maintained at a relatively higher oxygen 
supply than that in room air, the high pO2 values were attributable to systemic 
hyperoxygenation. In fact, pO2 of ascites showed a positive trend with pO2 of arterial 
blood in our patients; and pO2 of ascites obtained during laparotomy in 2 cases showed 
the same pO2 values (151 and 133 mm Hg), which were similar to those in the study by 
Noh et al. Our data, together with those of Noh et al., suggest that pO2 in malignant 
ascites with peritoneal metastasis may be somehow elevated as compared with that in 
cirrhotic ascites. 
Why is pO2 of malignant ascitic fluid so high? The efficiency of oxygen transfer 
through the peritoneum is considered to be elevated due to its rich vascular structure. 
Moreover, in peritoneal metastasis, vascular endothelial growth factor (VEGF) produced 
from tumor cells may further enhance the vascular permeability through tumor vessels 
[10]. The hyperpermeability condition may enable efficient oxygen delivery to peritoneal 
fluid via the microvessels lining the peritoneal cavity. In fact, the level of VEGF has been 
reported to be markedly high in malignant ascites [11, 12]. The use of bevacizumab, a 
humanized monoclonal antibody to VEGF, may reduce pO2 as well as the volume of 
ascites. 
In general, the oxygen tension in malignant tumor tissue is considerably decreased, 
and hypoxia is considered to be related to tumor progression and a poor outcome [13–
15]. A previous study to measure the oxygen partial pressure in tumors directly using an 
Eppendorf microelectrode demonstrated that pO2 in human solid tumors was less than 20 
mm Hg in most cases. This indicates that malignant ascites contained much more oxygen 
as compared with the primary tumor, and thus the high oxygen condition is thought to be 
a rather favorable condition for survival of disseminated tumor cells. This may be an 
important reason why so many tumor nodules can develop in the abdominal cavity.  
Case Rep Oncol 2010;3:344–348 
DOI: 10.1159/000321262 
Published online: 
October 1, 2010 
© 2010 S. Karger AG, Basel 
ISSN 1662–6575 
www.karger.com/cro 
 
 
347
In summary, ascites of peritoneal metastasis of gastric cancer shows a notably high 
level of pO2. Various therapeutic approaches, including systemic chemotherapy, 
hyperthermia, immune therapy as well as aggressive surgery, have been attempted for 
peritonitis carcinomatosa. However, none of these has achieved a satisfactory clinical 
outcome. Recently, however, intraperitoneal chemotherapy has been shown to be effective 
for peritoneal metastasis in ovarian and gastric cancer [5, 16]. Since the oxygen level 
critically affects the sensitivity of tumor cells to chemotherapeutic agents through 
metabolic transformation [17], the relatively high pO2 in malignant ascites is an 
important issue in considering the effectiveness of chemotherapy, especially 
intraperitoneal chemotherapy, for peritoneal metastasis. 
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Table 1. pH, pCO2 and pO2 in ascites and arterial blood of the patients with peritoneal metastasis of 
gastric cancer 
Ascites  Arterial blood gas (room air)    No. Age Sex  Method 
pH pCO2 pO2   pH  PaCO2 PaO2 
01 28 F bedside  7.317  45.3  108    7.405  46.6  100.2 
02 42 F bedside  7.363  46.4  082.8   7.449  38.1  090.5 
03 49 F bedside  7.371  49.8  083.2   7.422  42.3  085 
04 42 F bedside  7.371  45.9  077.5   ND ND  ND 
05 42 F laparotomy  7.437  38.9  151    7.449  38.1  090.5 
06 67 M  bedside  7.433  37.4  097   7.428  35.3 080.5 
07 32 M  bedside  7.404  45.8  100    7.441  39.7  115.7 
08 46 F laparotomy  7.64  27.8  133    7.416  46  084.2 
09 61 M  bedside  7.372  49  069   7.433  42.9 086.9 
10 56 F bedside  7.433  47  075.9   ND ND  ND 
11 59 M  bedside  7.405  39.6  083.8   7.458  39.4  104.7 
12 36 F bedside  7.42  45.4  085.4   7.474  38.7  092 
13 60 M  bedside  7.376  46.8  072.8   7.452  45  093.7 
14 38 F bedside  7.305  47.6  037.4   ND ND  ND 
15 56 F bedside  7.426  35.5  150    7.423  38.1  111.4 
16 63 F bedside  7.356  37.8  108    7.413  38.7  086.9 
17 43 M  bedside  7.387  43.8  085.3   7.437  43.2  097 
18 34 M  bedside  7.38  47  062.4   7.501  35.7  111 
19 47 F bedside  7.399  46.7  066.9   7.465  42  105.1 
20 45 F bedside  7.383  45.7  081.4   7.444  38.5  093 
21 40 M  bedside  7.346  48.4  087.5   7.421  44.8  101.4 
      Mean ± SD   7.39 ± 0.07  43.70 ± 5.50  090.40 ± 27.72  7.44 ± 0.02  40.73 ± 3.46  096.09 ± 10.33
Ascites were collected at bedside in 19 or just after laparotomy in 2 cases. ND = Not determined. 
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Fig. 1. Arterial blood and ascites were collected at bedside at room temperature in 16 patients and 
immediately measured with a blood gas analyzer. 
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